Company insight > Infection control Fighting septicaemia There has been a noticeable clinical impact of rapid diagnostics in the microbiology laboratory as AdvanDx’s peptide nucleic acid (PNA) technology enables fast - Acid-fast - Document - PDFSEARCH.IO

First Page	Meta Content
	Company insight > Infection control Fighting septicaemia There has been a noticeable clinical impact of rapid diagnostics in the microbiology laboratory as AdvanDx’s peptide nucleic acid (PNA) technology enables fast Add to Reading List Document Date: 2014-09-26 16:56:44 Open Document File Size: 510,78 KB Share Result on Facebook Company QuickFISH / / Currency USD / / IndustryTerm remarkable tools / molecular tools / / MedicalCondition Pseudomonas / septicaemia / S. aureus / Infection / sepsis / / MedicalTreatment antifungal therapy / antibiotic therapy / antibiotics / / Organization FDA / / Person Candida Staphylococcus / / Position physician / pharmacist for antimicrobial intervention / pharmacist / / Product fluconazole / / Technology Second-generation PNA technology / / URL www.hospitalmanagement.net / www.advandx.com/twodaysearlier / / SocialTag Pathogenic bacteria Bacterial diseases Bacteriology Staphylococcaceae Klebsiella pneumoniae Staphylococcus aureus Antimicrobial Norfloxacin Infection control Bacteria

Company insight > Infection control Fighting septicaemia There has been a noticeable clinical impact of rapid diagnostics in the microbiology laboratory as AdvanDx’s peptide nucleic acid (PNA) technology enables fast Add to Reading List